Monthly Archives: November 2018

Tivozanib expected to be included in European clinical practice guidelines for advanced kidney cancer

By Sharon Kell|2018-11-05T10:09:27+00:005 Nov 2018|Uncategorized|

Tivozanib is expected to be included as a first-line treatment [...]

Comments Off

A type of white blood cell as a potential biomarker to predict response to TKIs and overall survival

By Sharon Kell|2018-11-05T09:28:17+00:005 Nov 2018|Drug treatments|

A study investigating the prognostic and predictive value of a [...]

Comments Off

Almost half of all kidney cancer patients initially misdiagnosed

By Sharon Kell|2018-11-01T09:39:01+00:001 Nov 2018|Cancer news|

The results of the annual Kidney Cancer UK patient survey [...]

Comments Off

ESMO 2018: Interviews with the kidney cancer experts

By Sharon Kell|2018-11-01T09:01:07+00:001 Nov 2018|Drug treatments|

The following video interviews with kidney cancer experts from the [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org